CD4 and infection: Female controls exhibited higher baseline TRAV9-2 frequencies, suggesting a pre-existing, female-biased immune background associated with CCD susceptibility.<h4>Discussion</h4>A distinct CD4<sup>+</sup> TCR signature detectable six months post-infection characterizes patients who develop CCD.